KASAHARA Toshihiko | Toxicogenomics Project, National Institute of Biomedical Innovation
スポンサーリンク
概要
関連著者
-
KASAHARA Toshihiko
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Kasahara Toshihiko
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Nagao Taku
Food Safety Commission Of Japan
-
Nagao Taku
Laboratory Of Pharmacology & Toxicology Graduate School Of Pharmaceutical Sciences The Universit
-
Nagao Taku
Laboratory Of Pharmacology And Toxicology Graduate School Of Pharmaceutical Sciences The University
-
MIYAGISHIMA Toshikazu
Toxicogenomics Project, National Institute of Biomedical Innovation
-
URUSHIDANI Tetsuro
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Urushidani Tetsuro
Toxicogenomics Project National Institute Of Biomedical Innovation:department Of Pathophysiology Dos
-
Miyagishima Toshikazu
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Urushidani Tetsuro
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Miwa Satoko
Exploratory Toxicology & Dmpk Research Laboratories Tanabe Seiyaku Co. Ltd.
-
Urushidani Tetsuro
Laboratory Of Pharmacology & Toxicology Graduate School Of Pharmaceutical Sciences The Universit
-
NAGAO Taku
Toxicogenomics Project, National Institute of Health Sciences (NIHS)
-
Ono Atsushi
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Ono Atsushi
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Okuyama Manabu
国立医薬品食品衛生研究所
-
Okuyama Manabu
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Okuyama Manabu
医薬基盤研究所 トキシコゲノミクスプロジェクト
-
MORISHITA Katsumi
Toxicogenomics Project, National Institute of Biomedical Innovation
-
TAKASHIMA Kayoko
Toxicogenomics Project, National Institute of Biomedical Innovation
-
TORITSUKA Naoki
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Torituka Naoki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Toritsuka Naoki
Drug Safety Research Labolatories Eisai Co. Ltd.
-
Takashima Kayoko
Toxicogenomics Project National Institute Of Health Sciences
-
Takashima Kayoko
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Morishita Katsumi
Toxicogenomics Project National Institute Of Biomedical Innovation
-
HARADA Tsuyoshi
Toxicology Laboratory, Mochida Pharmaceutical Co., Ltd.
-
MIYAZAKI Toshiko
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Harada Tsuyoshi
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
Ono Atsushi
Toxicogenomics Informatics Project, National Institute of Biomedical Innovation
-
NAGAO Taku
National Institute of Health Sciences
-
KASAHARA Toshihiko
Pharmaceutical Research Center
-
HASHIBA Masamichi
Toxicology Laboratory, Mochida Pharmaceutical Co., Ltd.
-
OBATA Masaomi
Toxicology Laboratory, Mochida Pharmaceutical Co., Ltd.
-
TORITUKA Naoki
Toxicogenomics Project National Institute of Health Sciences (NIHS)
-
Obata Masaomi
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
Obata Masaomi
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Nitta Hiroyuki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Hashiba Masamichi
Department Of Molecular Toxicology And The 21st Century Coe Program School Of Pharmaceutical Science
-
Kasahara Toshihiko
Department Of Molecular Toxicology And The 21st Century Coe Program School Of Pharmaceutical Science
-
Toritsuka Naoki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Nagao Taku
National Institute Of Health Sci.
-
Harada Tsuyoshi
Development Research Mochida Pharmaceutical Co. Ltd.
-
MORI Yutaka
Department of Radiology, Jikei University School of Medicine
-
Tajima Naoko
Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei Universit
-
Mori Yutaka
Department Of Internal Medicine National Hospital Organization Utsunomiya National Hospital
-
Tajima N
Jikei Univ. School Of Medicine
-
HAMADA YOSHIMASA
Toxicology, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer In
-
MIZUKAWA Yumiko
Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liber
-
SUZUKI Takamasa
Toxicogenomics Project, National Institute of Health Sciences (NIHS)
-
MORISHITA Katumi
Toxicogenomics Project National Institute of Health Sciences (NIHS)
-
Suzuki Takamasa
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Nobukata Hidefumi
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
Kasahara Toshihiko
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
OCHIAI Toshiaki
Toxicology Laboratory, Research Center, Mochida Pharmaceutical Co., Ltd.
-
Mizukawa Yumiko
Toxicogenomics Project National Institute Of Biomedical Innovation:department Of Pathophysiology Fac
-
Ochiai Toshiaki
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
Ochiai Toshiaki
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Ueda Hiroyuki
Toxicogenomics Project, National Institute of Health Sciences (NIHS)
-
Tajima Naoko
Division Of Diabeters Metabolism And Endocrinology Department Of Internal Medicine Jikei University
-
Hamada Yoshimasa
Toxicology Laboratory Research Center Mochida Pharmaceutical Co. Ltd.
-
Hamada Yoshimasa
Toxicology Laboratory Mochida Pharmaceutical Co. Ltd.
-
Mori Yutaka
Department Of Internal Medicine National Higashi-utsunomiya Hospital
-
Mori Yutaka
Department Of Chemistry
-
Ueda Hiroyuki
Toxicogenomics Project National Institute Of Health Sciences (nihs)
-
Mori Yutaka
Department Of Applied Chemistry Graduate School Of Engineering Osaka City University
著作論文
- GENE EXPRESSION PROFILE IN LIVER OF DIFFERING AGES OF RATS AFTER SINGLE ORAL ADMINISTRATION OF ACETAMINOPHEN
- P6-54 DNAmicroarray analysis of time-dependent change of gene expression in rat primary hepatocyte cultured in serum-containing or-free medium(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-53 Comparison of gene expression profile of the liver after Phenobarbital treatment in vivo and in vitro(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-51 Gene Expression Profile in the Liver from Different Age of Rats after Single Oral Dose of Acetaminophen(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P-12 Application of RT-PCR for analysis of hepatic drugmetabolizing enzyme induction in rats treated with tamoxifen.(Proceedings of the 27th Annual Meeting)
- O-34 Reverse transcription polymerase reaction (RTPCR) analysis of proto-oncogene expression induced by tamoxifen in rat liver.(Proceedings of the 27th Annual Meeting)
- Long-Term Administration of Highly Purified Eicosapentaenoic Acid Ethyl Ester Improves Blood Coagulation Abnormalities and Dysfunction of Vascular Endothelial Cells in Otsuka Long-Evans Tokushima Fatty Rats
- EVALUATION OF METHODS FOR DURATION OF PRESERVATION OF RNA QUALITY IN RAT LIVER USED FOR TRANSCRIPTOME ANALYSIS
- Evaluation of preservation methods for rat liver : (2) Condition of preservation for rat liver tissue dissolved in RLT buffer(Toxicogenomics, Toxicoproteomics, Proceedings of the 32nd Annual Meeting)
- Effects of various chemicals on transporter genes in rat liver and primary cultured hepatocytes(Toxicogenomics, Toxicoproteomics, Proceedings of the 32nd Annual Meeting)
- Evaluation of preservation methods for rat liver : (1) Evaluation of tissue preservation by using RNAlater(Toxicogenomics, Toxicoproteomics, Proceedings of the 32nd Annual Meeting)
- Evaluation of preservation methods for rat liver : (3) Influence of time to preservation of liver tissue on RNA quality(Toxicogenomics, Toxicoproteomics, Proceedings of the 32nd Annual Meeting)